![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 46, 32547-32550, November 12, 1999
-D-GLUCOSIDE*
From the Australian Cataract Research Foundation, University of Wollongong, Wollongong, New South Wales 2522, Australia
| |
ABSTRACT |
|---|
|
|
|---|
The human lens becomes increasingly yellow with
age and thereby reduces our perception of blue light. This coloration
is associated with lens proteins (crystallins), but its molecular basis
was unknown. Here we show that the coloration occurs because of the interaction of crystallins with a UV filter compound,
3-hydroxykynurenine glucoside (3-OHKG). Crystallin modification results
from deamination of the 3-OHKG amino acid side chain, yielding an
unsaturated ketone that is susceptible to nucleophilic attack by
cysteine, histidine, and lysine residues. This novel protein
modification contributes to age-related lens coloration and may play a
role in human nuclear cataractogenesis.
As part of the normal process of aging, the human lens becomes
progressively more yellow and fluorescent (1-3), leading to a
concomitant increase in light absorption in the 300-500 nm range (1)
and thus diminishes our perception of violet and blue light. The
age-related increase in lens coloration and fluorescence is associated
with the major proteins of the lens, the crystallins, and is
particularly prominent in the lens nucleus (2, 3). Because there is
little or no protein turnover in the lens nucleus (4), the proteins are
as old as the individual. The post-translational modifications that
result in crystallin coloration, therefore, accumulate throughout life
and may eventually contribute to age-related nuclear cataract. The
latter condition is characterized by a brown coloration of the lens
nucleus and extensive protein oxidation (5, 6). The human lens also
contains a family of Trp-derived UV filter compounds, of which
3-OHKG1 is present at the
highest concentration ( We have recently elucidated a novel pathway that leads to the formation
of a glutathione (GSH) adduct of 3-OHKG in the human lens (12). The
GSH-3-OHKG adduct was formed via deamination of the 3-OHKG amino acid
side chain to form an Materials--
All organic solvents were HPLC grade (Ajax,
Unichrom, Auburn, NSW, Australia). Poly-L-lysine was from
Sigma, trifluoroacetic acid (>99% pure) was from Aldrich, and acetic
acid (>99.8% pure) from BDH (Poole, UK). 3-hydroxykynurenine
O- Human Lens Treatments--
Human lenses were obtained from donor
eyes used for corneal grafting with ethical approval from the Eastern
Sydney Area Health Service-Research Ethics Committee (Ref. 90/057) and
the University of Wollongong Human Ethics Committee (Ref. HE96/145). A
total of 55 lenses, ranging in age from 14 to 85 years, were obtained from the Sydney Lions Eye Bank, the Queensland Lions Eye Bank, or
kindly provided by Dr B. Ortwerth (University of Missouri, Columbia,
MO.). Lenses were homogenized in 0.5 ml of 80% ethanol, placed on ice
for 30 min, and then centrifuged (10,000 × g, 10 min,
4 °C) and the supernatant discarded. This procedure was repeated an
additional three times to remove low molecular weight compounds including unbound UV filters. The protein pellets were lyophilized, and
approximately 30 mg was weighed into screw-capped glass vials. Potassium hydroxide 5% (w/v) in 80% (v/v) ethanol/water (10 ml) was
added, and the vial was wrapped in foil to exclude light, bubbled with
argon, and sealed prior to incubation (25 °C, 48 h). An aliquot
(5 ml) was then adjusted to between pH 5 and 7 with 3 M HCl
and lyophilized. One ml of 0.05% trifluoroacetic acid (v/v) in water
was added to the dried pellet, the mixture centrifuged for 10 min at
10, 000 × g, and a 50-µl sample analyzed by
HPLC.
Incubation of Calf Lens Protein (CLP) or Polylysine with
3-OHKG--
One hundred mg of lyophilized CLP or polylysine was
dissolved in 25 mM sodium carbonate/bicarbonate buffer, pH
7 or 9 (10 ml). Synthetic 3-OHKG (10 mg) was added together with 40 µl of chloroform. The tube was wrapped in foil, bubbled with argon, sealed, and incubated for up to 24 days at 37 °C. Aliquots (2 ml)
were removed every 48 h (or at longer intervals beyond 8 days) and
chromatographed through Sephadex G25 (Amersham Pharmacia Biotech) equilibrated in distilled water. The protein fraction was extracted with ethanol four times, and in two experiments the ethanol-extracted lens protein was lyophilized, dissolved in 6 M guanidine
hydrochloride, and dialyzed against 1000 volumes of water to ensure
that any non-covalently associated UV filters were removed. Because the additional dialysis step did not affect the recovery of AHAG, we
concluded that the multiple ethanol extraction was sufficient to remove
all low molecular weight compounds. Lyophilized proteins were
redissolved in 1 ml of 6 M guanidine hydrochloride prior to
measuring UV absorbance and fluorescence. 3-OHKG-modified CLP and
polylysine samples were also subjected to base hydrolysis and HPLC
analysis of AHAG as described below.
HPLC Analysis of AHAG--
HPLC analysis was performed using a
Varian (Microsorb-MV C-18, 4.6 × 250 mm, 300 Å) column with the
following mobile phase conditions: 0.05% trifluoroacetic acid for 5 min followed by a linear gradient of 0-80% acetonitrile/0.05%
trifluoroacetic acid over 15 min with a flow rate of 1 ml/min.
Detection was at 365 nm, and AHAG eluted at 13 min. Confirmation of the
identity of AHAG in the base hydrolysate from human lens proteins was
obtained using LC-ESIMS (see below) and by comparison with an authentic standard of AHAG (14). Synthetic AHAG was used to construct a standard
curve for quantification of lens-derived AHAG by HPLC. The recovery of
AHAG after base treatment was assessed by hydrolyzing a synthetic
sample of 3-OHKG that had been conjugated previously with GSH (12) and
by extending hydrolysis times of modified crystallins until no further
AHAG was liberated. The yield of AHAG from modified crystallins after
48 h of hydrolysis was thus estimated to be 85%.
Mass Spectrometry and LC-ESIMS--
Peaks that eluted from the
Microsorb HPLC column were collected and further analyzed by microbore
HPLC (Applied Biosystems, Model 172 Separation System, Foster City, CA)
using an Alltima 250 × 2.1 mm, C18 column (catalog no. 88371, Alltech, Deerfield, IL). Samples were routinely eluted using an
acetonitrile gradient in aqueous 4 mM ammonium acetate (pH
5) and a flow rate of 200 µl/min. The gradient was run linearly from
0 to 40% acetonitrile over 40 min. Eluted compounds were detected by
monitoring absorbance at 360 nm and by in-line electrospray ionization
mass spectrometry (LC-ESIMS). Mass spectra were obtained on a VG
Quattro quadrupole mass spectrometer (VG Biotech, Altrincham, UK)
equipped with an upgraded ESI source. Mass spectra were acquired in
positive ion mode with a scan rate of 100 m/z /s.
The source was maintained at 150 °C.
Fluorescence and UV-visible Absorption Spectrophotometric
Measurements--
UV-visible absorbance spectra were obtained using a
Shimadzu UV-265 spectrophotometer (Kyoto, Japan), and fluorescence
spectra were recorded on a Hitachi F-4500 fluorescence spectrometer
(Tokyo, Japan) in three-dimensional scan mode.
Modification of CLP with 3-OHKG--
Our initial studies focused
on the ability of 3-OHKG to form covalent adducts with crystallins.
3-OHKG was therefore synthesized (13) and examined for its reactivity
toward proteins. Following incubation with 3-OHKG, lens proteins
developed coloration (365 nm) and fluorescence (Ex 380 nm/Em 490)
linearly with time of incubation (Fig.
1a). Binding of the UV filter
was increased approximately 10-fold if the pH was increased from 7 to 9 (Fig. 1b), consistent with our observations on the effect of
pH on GSH-3-OHKG formation (12).
It is known that the amino acid side chain of kynurenine is susceptible
to hydrolysis by strong base, producing an acetophenone derivative
(15). In agreement with this we found that 3-OHKG, and molecules
containing this moiety (i.e. GSH-3-OHKG and protein-3-OHKG adducts), are cleaved to release AHAG. This result is illustrated in
Reaction 1, where a cysteinyl adduct is
given as an example and "X" and "Y" represent amino acid
residues in the protein. The extent of binding of 3-OHKG to protein was
therefore also assessed by base hydrolysis of the protein followed by
quantification of AHAG released. Fig. 1c shows that AHAG was
released from the 3-OHKG-modified crystallins, suggesting that the
covalent modification was analogous to that of the GSH-3-OHKG adduct
(12).
Liberation of AHAG from Human Crystallins--
To determine
whether human crystallins are also covalently modified by 3-OHKG
in vivo, lenses of various ages were examined, and the
quantity of AHAG released from the proteins was plotted as a function
of age (Fig. 2). AHAG has been isolated
previously from cataractous lenses following treatment with base,
although its origin was not investigated (16). In the present work, an age-dependent increase in AHAG was observed that was more
pronounced in lenses over 40 years old, although considerable scatter
was evident (Fig. 2). The inset in Fig. 2 illustrates that,
in the case of GSH-3-OHKG, base hydrolysis is complete within 48 h
with quantitative recovery. More than half (85%) of the AHAG was
released from the modified crystallins within 48 h (Fig. 2,
inset). Duplicate samples of 22 of the lenses over 40 years
old were also incubated for 144 h. This action resulted in a 15%
increase in AHAG detected, on average, but did not reduce the
variability (scatter) of the data depicted in Fig. 2. Significant
variation in the extent of UV filter-mediated modification of
crystallins do, therefore, exist in our study population. We estimate,
based on the molar absorptivity of GSH-3-OHKG (12) compared with the
known increase in lenticular absorption of light at 360 nm (1), that at
least 50% of the increase in age-related lenticular color in humans may be attributed to binding of 3-OHKG.
Confirmation of the structure of liberated AHAG was obtained via
microbore HPLC with LC-ESIMS and by comparison with an authentic standard synthesized (14) in our laboratory. Fig.
3 shows that the AHAG released from the
isolated human lens proteins displayed a positive ion at
m/z 314, with a fragment ion at
m/z 152, consistent with the molecular mass of
AHAG (313 Da) and its aglucone (151 Da). This mass spectrum was
identical to the synthetic AHAG (Fig. 3). The lens-derived AHAG and the
synthetic standard also co-eluted when they were mixed together and
analyzed by LC-ESIMS. These data provide the first chemical evidence
that 3-OHKG forms adducts with human lens proteins according to the
mechanism we have proposed, which involves addition at the Three-dimensional Fluorescence Plots of 3-OHKG-Modified
Crystallins--
A well known feature of human lenses is the
development of non-Trp (or "blue") fluorescence, which increases in
intensity with age (17). Examination of CLP incubated with 3-OHKG at pH 7 for 16 days revealed that they became fluorescent (Fig.
1a). A comparison of the three-dimensional fluorescence
spectra of 3-OHKG-treated CLP with crystallins isolated from older
human lenses showed that they were almost identical (Fig.
4). In both samples, several prominent
fluorophores were identified. A major fluorophore exhibited maximum
intensity at Ex 380 nm/Em 490 nm, consistent with previous observations
(18). The intensity of this fluorophore, which has been documented to
increase with age (18), also increased with the time of incubation in
our model system, and this may be attributed to binding of 3-OHKG to
protein (Fig. 1). The protein fluorescence spectra are considerably
more complex than 3-OHKG itself, which displays a single peak (Ex 357 nm/Em 500 nm) (19).
The attachment of 3-OHKG appears to take place via initial deamination
of the amino acid side chain of 3-OHKG, yielding an unsaturated ketone
that is then susceptible to attack by nucleophilic amino acids such as
histidine, cysteine, or lysine residues in the protein. In support of
this proposal, when polylysine was incubated in the presence of 3-OHKG,
it showed a similar time-dependent increase in fluorescence
and color as well as AHAG release following base hydrolysis.
Derivatives of 3-OHKG such as
The intrinsic instability of the kynurenine side chain to deamination,
which underlies the binding to lens proteins reported here, also
appears responsible for the formation of other UV filter compounds such
as AHBG (20). Thus, conjugation with GSH (12) or reduction to form AHBG
may effectively compete with lens crystallins for the reactive product
that results from deamination of 3-OHKG. The observed increase in the
extent of binding of 3-OHKG to lens protein after the age of 40-50
(Fig. 2) may result in part from a diminished concentration of reduced
GSH in the nuclear region of the lens (23, 24). This feature may result
from the development of a barrier to the diffusion of GSH, from its
site of synthesis (or reduction) in the lens cortex to the interior of
the lens (23).
Because other UV filters present in the human lens, such as kynurenine
and 3-hydroxykynurenine (7, 8), contain the same amino acid side chain
as 3-OHKG, it would be expected that these would also bind to lens
proteins. We have shown this to be the case using kynurenine and
isolated
Another interesting aspect of the mode of 3-OHKG-mediated protein
modification is that it does not require oxidation and can therefore
take place in the normal human lens. Oxidation is, however, a hallmark
of age-related nuclear cataract (5, 6), and we speculate that the
pronounced coloration that characterizes age-related nuclear
cataractous lenses may result from oxidative reactions involving
protein-bound UV filters (e.g. 3-hydroxykynurenine) that
have accumulated over the lifetime of the individual.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
500 µM) (7, 8). These UV
filters are thought to play a protective role by preventing potentially
damaging UV light from reaching the retina. Several investigators have
considered the possibility that the UV filters could covalently modify
lens crystallins with deleterious consequences, including alteration of
protein conformation and increased sensitivity to UV light (9-11).
However, the mechanism leading to crystallin modification by 3-OHKG was
not determined nor was there any evidence that 3-OHKG induces protein
modification in vivo.
,
-unsaturated carbonyl that was highly
susceptible to nucleophilic attack by the cysteine of GSH (12). The aim
of the present studies is to assess the relevance of analagous
reactions in the modification of crystallins and also to probe for
evidence of crystallin-3-OHKG adducts in human lenses.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-D-glucoside (3-OHKG) and
2-amino-3-hydroxyacetophenone O-
-D-glucoside
(AHAG) were synthesized (13, 14) in our laboratory. Milli-Q water
(purified to 18 megaohms cm
2) was used in the preparation
of all solutions. Calf lenses were obtained from Parish meats, Yallah,
NSW, Australia.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
Covalent modification of crystallins by
3-OHKG and formation of colored/fluorescent proteins that yield AHAG
upon base hydrolysis. Calf lens protein was incubated with 3-OHKG
for 24 days at pH 7 (a) or 8 days at pH 9. (b).
UV absorbance (
) and relative fluorescence (
) are shown
(a, b). Slit widths for the fluorescence
measurements are Ex 10 nm/Em 5 nm (a) and Ex 5 nm/Em 5 nm
(b). The fluorescence intensity on day 24, pH 7, was
one-sixth that for day 8, pH 9 (Ex 380/Em 5 nm). The amount of AHAG
liberated after a 48-h base hydrolysis of the samples from b
is also shown in c.

View larger version (8K):
[in a new window]
Reaction 1.

View larger version (22K):
[in a new window]
Fig. 2.
AHAG liberated from human lens proteins as a
function of age. Fifty-five lenses were extracted with 80% (v/v)
ethanol/water four times to remove unbound UV filters. The lyophilized
protein was incubated for 48 h in 5% (w/v) potassium hydroxide in
80% (v/v) ethanol to liberate AHAG, which was quantified by HPLC. The
inset shows time course experiments for the base hydrolysis
of the GSH-3-OHKG adduct (
) and lens proteins (
). In the latter
case, the data are means with the error bars showing S.E.,
where n = 2, 3, 22, 3, and 22 samples for the times
0.5, 1, 2, 4, and 6 days, respectively. The percentage recovery of AHAG
from lens proteins was shown to increase by approximately 15% when the
incubation time was increased from 2 to 6 days. For reasons of
practicality, the 48-h incubation was adopted as the routine hydrolysis
procedure.
C of the
side chain (see Reaction 1).

View larger version (16K):
[in a new window]
Fig. 3.
Mass spectra of synthetic and lens
protein-derived AHAG. The AHAG was either derived from base
hydrolysis of human lens crystallins (a) or synthesized
(b) as described under "Experimental Procedures."
Samples were analyzed using microbore HPLC with in-line electrospray
ionization mass spectrometry. The positive ion mass spectra shown are
for the single 360 nm-absorbing compounds present and were determined
directly after elution from the HPLC column. The y ordinates
show relative signal intensity.

View larger version (49K):
[in a new window]
Fig. 4.
Fluorescence spectra of 3-OHKG-modified
crystallins. Three-dimensional fluorescence spectra of calf lens
protein following incubation with 3-OHKG at pH 7 for 16 days
(a) (slit widths, Ex 10 nm/Em 5 nm) and 75-year-old human
lens protein (b) (slit widths, Ex 5 nm/Em 5 nm) are shown.
Both samples were isolated after removal of low molecular weight
compounds by Sephadex G25 chromatography followed by multiple ethanol
extractions and dialysis against water. The concentration of both
samples was 1 mg of protein/ml in 6 M guanidine
hydrochloride. Calf lens proteins did not exhibit non-tryptophan
fluorescence prior to incubation.
-N-acetyl 3-OHKG (13) and
4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid
O-
-D-glucoside (AHBG) (19, 20), which cannot
undergo deamination, failed to bind to lens proteins. Two factors
account for the increased covalent modification of crystallins by
3-OHKG when pH is increased from 7 to 9. First, deamination of the
kynurenine side chain is favored at the higher pH (21), and second, the
nucleophilicity of amino acids (including cysteine, histidine, and
lysine) is closely related to their pKa values
(22).
,
, and
crystallins, all of which bound the UV
filter. Peptide sequence analysis has revealed that the major sites of
modification in lens crystallins in vitro are at histidine,
cysteine, and lysine
residues.2 We are currently
mapping specific kynurenine- and 3-OHKG-modified sites in human crystallins.
| |
ACKNOWLEDGEMENTS |
|---|
We acknowledge the helpful suggestions of Kay Truelove (Art Gallery of New South Wales Research Library) in researching the effects of impaired vision on painting. We thank Prof. Roger Dean (The Heart Research Institute, Sydney, Australia) for critical comments on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by Australian National Health and Medical Research Council Grant 980495 (to R. J. W. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Australian Cataract
Research Foundation, Dept. of Chemistry, University of Wollongong, Wollongong, NSW 2522, Australia. Fax: 61-2-42214287; E-mail:
roger_truscott@uow.edu.au.
2 B. Garner and R. J. W. Truscott, unpublished observation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
3-OHKG, 3-hydroxykynurenine O-
-D-glucoside;
AHAG, 2-amino-3-hydroxyacetophenone O-
-D-glucoside;
AHBG, 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid
O-
-D-glucoside;
CLP, calf lens
protein;
Ex/Em, excitation/emission;
HPLC, high pressure liquid
chromatography;
LC-ESIMS, liquid chromatography-electrospray ionization
mass spectrometry.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Weale, R. A.
(1988)
J. Physiol. (Lond.)
395,
577-587 |
| 2. | Lerman, S., and Borkman, R. (1976) Ophthalmic Res. 8, 335-353 |
| 3. |
Bessems, G. J. H.,
Keizer, E.,
Wollensak, J.,
and Hoenders, H. J.
(1987)
Investig. Ophthalmol. Vis. Sci.
28,
1157-1163 |
| 4. |
Bloemendal, H.
(1977)
Science
197,
127-138 |
| 5. | Truscott, R. J. W., and Augusteyn, R. C. (1977) Exp. Eye Res. 24, 159-170[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Fu, S.,
Dean, R.,
Southan, M.,
and Truscott, R. J. W.
(1998)
J. Biol. Chem.
273,
28603-28609 |
| 7. | van Heyningen, R. (1971) Nature 230, 393-394[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Wood, A. M., and Truscott, R. J. W. (1993) Exp. Eye Res. 56, 317-325[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Stutchbury, G. M., and Truscott, R. J. W. (1993) Exp. Eye Res. 57, 149-155[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Bando, M., Mikuni, I., and Obazawa, H. (1985) Exp. Eye Res. 40, 813-818[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Dillon, J., Skonieczna, M., Mandal, K., and Paik, D. (1999) Photochem. Photobiol. 69, 248-253[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Garner, B.,
Vazquez, S.,
Griffith, R.,
Lindner, R. A.,
Carver, J. A.,
and Truscott, R. J. W.
(1999)
J. Biol. Chem.
274,
20847-20854 |
| 13. | Manthey, M. K., Jamie, J. F., and Truscott, R. J. W. (1999) J. Org. Chem. 64, 3930-3933[CrossRef] |
| 14. | Das, S. K., and Saha, U. K. (1994) Bioorg. & Med. Chem. Lett. 4, 1219-1220[CrossRef] |
| 15. | Tokuyama, T., Seno, S., Hirose, Y., and Sakan, T. (1958) J. Chem. Soc. Japan 79, 152-761 |
| 16. | Inoue, A., and Satoh, K. (1993) Bioorg. & Med. Chem. Lett. 3, 345-346 |
| 17. | Yu, N.-T., Barron, B. C., and Kuck, J. F. R. (1989) Exp. Eye Res. 49, 189-194[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Yappert, M. C.,
Sundeep, L.,
and Borchman, D.
(1992)
Investig. Ophthalmol. Vis. Sci.
33,
3555-3560 |
| 19. | Truscott, R. J. W., Wood, A. M., Carver, J. A., Sheil, M. M., Stutchbury, G. M., Zhu, J., and Kilby, G. W. (1994) FEBS Lett. 348, 173-176[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Bova, L. M., Wood, A. M., Jamie, J. F., and Truscott, R. J. W. (1999) Investig. Ophthalmol. Vis. Sci., in press |
| 21. | Tokuyama, T., Senoh, S., Sakan, T., Brown, K. S., and Witkop, B. (1967) J. Am. Chem. Soc. 89, 1017-1021[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Friedman, M., and Wall, J. S. (1964) J. Am. Chem. Soc. 86, 3735-3741[CrossRef] |
| 23. | Sweeney, M. H. J., and Truscott, R. J. W. (1998) Exp. Eye Res. 67, 587-595[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Dickerson, J. E., and Lou, M. F. (1997) Exp. Eye Res. 65, 451-454[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
N. R. Parker, A. Korlimbinis, J. F. Jamie, M. J. Davies, and R. J. W. Truscott Reversible Binding of Kynurenine to Lens Proteins: Potential Protection by Glutathione in Young Lenses Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3705 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Korlimbinis, J. A. Aquilina, and R. J. W. Truscott Protein-Bound UV Filters in Normal Human Lenses: The Concentration of Bound UV Filters Equals That of Free UV Filters in the Center of Older Lenses Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1718 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fan, L. W. Reneker, M. E. Obrenovich, C. Strauch, R. Cheng, S. M. Jarvis, B. J. Ortwerth, and V. M. Monnier Vitamin C mediates chemical aging of lens crystallins by the Maillard reaction in a humanized mouse model PNAS, November 7, 2006; 103(45): 16912 - 16917. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Bringans, J. M. Dyer, J. E. Plowman, and W. G. Bryson Kynurenine Located within Keratin Proteins Isolated from Photoyellowed Wool Fabric Textile Research Journal, April 1, 2006; 76(4): 288 - 294. [Abstract] [PDF] |
||||
![]() |
M. M. Staniszewska and R. H. Nagaraj 3-Hydroxykynurenine-mediated Modification of Human Lens Proteins: STRUCTURE DETERMINATION OF A MAJOR MODIFICATION USING A MONOCLONAL ANTIBODY J. Biol. Chem., June 10, 2005; 280(23): 22154 - 22164. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sala, M. Campagnoli, E. Perani, A. Romano, S. Labo, E. Monzani, L. Minchiotti, and M. Galliano Human {alpha}-1-Microglobulin Is Covalently Bound to Kynurenine-derived Chromophores J. Biol. Chem., December 3, 2004; 279(49): 51033 - 51041. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Streete, J. F. Jamie, and R. J. W. Truscott Lenticular Levels of Amino Acids and Free UV Filters Differ Significantly between Normals and Cataract Patients Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4091 - 4098. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cheng, Q. Feng, O. K. Argirov, and B. J. Ortwerth Structure Elucidation of a Novel Yellow Chromophore from Human Lens Protein J. Biol. Chem., October 29, 2004; 279(44): 45441 - 45449. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vazquez, N. R. Parker, M. Sheil, and R. J. W. Truscott Protein-Bound Kynurenine Decreases with the Progression of Age-Related Nuclear Cataract Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 879 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Han, J. Fang, and J. Li 3-Hydroxykynurenine Transaminase Identity with Alanine Glyoxylate Transaminase. A PROBABLE DETOXIFICATION PROTEIN IN AEDES AEGYPTI J. Biol. Chem., May 3, 2002; 277(18): 15781 - 15787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vazquez, J. A. Aquilina, J. F. Jamie, M. M. Sheil, and R. J. W. Truscott Novel Protein Modification by Kynurenine in Human Lenses J. Biol. Chem., February 8, 2002; 277(7): 4867 - 4873. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bova, M. H. J. Sweeney, J. F. Jamie, and R. J. W. Truscott Major Changes in Human Ocular UV Protection with Age Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 200 - 205. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |